Philippe Motté
Founder at Celestial Consulting & Coaching
Philippe Motté active positions
Companies | Position | Start | End |
---|---|---|---|
Celestial Consulting & Coaching | Founder | 31/05/2018 | - |
President | 31/05/2018 | - | |
Académie nationale de Pharmacie | Corporate Officer/Principal | - | - |
Career history of Philippe Motté
Former positions of Philippe Motté
Companies | Position | Start | End |
---|---|---|---|
GENFIT | General Counsel | 31/05/2020 | 31/07/2022 |
MedDay Pharmaceuticals SAS
MedDay Pharmaceuticals SAS BiotechnologyHealth Technology MedDay Pharmaceuticals SAS operates as a biotechnology company developing new drugs for nervous system disorders. The firm operates for the treatment of neuro-metabolic diseases. The company was founded by Frédéric Sedel and Guillaume Brion in 2011 and is headquartered in Paris, France. | Corporate Officer/Principal | 30/04/2019 | 31/05/2020 |
GENSIGHT BIOLOGICS S.A. | General Counsel | 11/09/2022 | - |
Training of Philippe Motté
ESCP Europe Campus London | Masters Business Admin |
Université Paris-Saclay | Doctorate Degree |
Universite Paris Cite | Doctorate Degree |
Statistics
International
France | 8 |
United Kingdom | 2 |
Operational
General Counsel | 2 |
Doctorate Degree | 2 |
Corporate Officer/Principal | 2 |
Sectoral
Health Technology | 4 |
Consumer Services | 4 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 2 |
---|---|
GENFIT | Health Technology |
GENSIGHT BIOLOGICS S.A. | Health Technology |
Private companies | 3 |
---|---|
Celestial Consulting & Coaching | |
Académie nationale de Pharmacie | |
MedDay Pharmaceuticals SAS
MedDay Pharmaceuticals SAS BiotechnologyHealth Technology MedDay Pharmaceuticals SAS operates as a biotechnology company developing new drugs for nervous system disorders. The firm operates for the treatment of neuro-metabolic diseases. The company was founded by Frédéric Sedel and Guillaume Brion in 2011 and is headquartered in Paris, France. | Health Technology |
- Stock Market
- Insiders
- Philippe Motté
- Experience